Free Tdap vaccine now available nationwide for pregnant women in Malaysia

Although receiving the Tdap vaccine is not compulsory, the Health Ministry strongly encourages pregnant women to take part in this programme, aligning with the national life-course immunisation approach.

WT default author logo
Women's Tabloid News Desk

In a move aimed at strengthening protection for newborns, the Ministry of Health has introduced free Tdap (tetanus-diphtheria-pertussis) vaccinations for pregnant women between 28 and 32 weeks of gestation. This nationwide initiative is now in effect at all MOH primary healthcare centres that provide maternity services.

The announcement was made by Health Minister Datuk Seri Dr Dzulkefly Ahmad during the National Immunisation Day celebration. He explained that the immunisation effort is part of a broader strategy to safeguard infants, particularly from pertussis, commonly known as whooping cough, before they can complete their standard vaccination schedule.

“This vaccine aims to provide early protection to newborns who are highly vulnerable to complications from pertussis before completing their vaccination schedule,” said Dr Dzulkefly.

He further assured the public of the vaccine’s reliability, referencing global data on its use.
“International studies have also shown that this vaccine is safe and effective, without increasing risks to either mother or baby,” he said.

Although receiving the Tdap vaccine is not compulsory, the Health Ministry strongly encourages pregnant women to take part in this programme, aligning with the national life-course immunisation approach.

During the same event, Dr Dzulkefly shared an update on the Influenza Vaccination Programme for senior citizens, which began on February 18. It targets Malaysians aged 60 and above who live with chronic conditions. As of the latest count, 97,355 elderly individuals have received the influenza vaccine at public clinics across the country.

Emphasising the importance of public trust in medical programmes, Dr Dzulkefly addressed concerns about misinformation, noting that Malaysia’s national immunisation policy is regularly reviewed based on scientific research and international standards, with all vaccines undergoing rigorous efficacy and safety evaluations by the National Pharmaceutical Regulatory Agency (NPRA) and continuous monitoring by the Ministry of Health.

“There is a growing concern regarding the false dissemination of fake news and information, and this undermines public confidence. I understand that some parents are still unsure.

“I urge everyone to always refer to official sources because our decision today will affect the health of future generations,” he said.

With this new measure, the ministry reinforces its commitment to evidence-based policy, aiming to provide accessible and timely immunisation for key population groups.

Share:

Related Insights

Women to have greater say in care under renewed health strategy

Eka Ventures becomes UK’s largest early-stage impact VC with $107 million fund close

Sibel Health wins FDA clearance for wireless maternal monitoring system

Noom acquires licensed pharmacy to expand into healthy aging and preventive care

Blackstone and TPG complete acquisition of Hologic with new chief executive at the helm

Adela Ida Jiram appointed as first Iban woman to lead MSPTM

New menopause action plan comes at right time as survey shows just 18% of women’s work have menopause policy

Prickly Pear Health expands pre-seed funding for women’s brain health